The results presented in this paper showing that sFRP1-mediated WNT pathway blockade strongly blocks the in vivo tumor forming potential of MDA-MB-231 breast cancer cells suggest that interference with WNT signaling at the ligand-receptor level may be a valid therapeutic approach in breast cancer. This evidence concerns the gene SFRP1 and breast cancer.